Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1TR002489, 1K12TR004416-01, 1K12TR004416-01)
National Institute of Allergy and Infectious Diseases (T32AI007062)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (U19AR069522, U19AR069522)
American Academy of Allergy, Asthma and Immunology Foundation,United States
National Heart, Lung, and Blood Institute (R01HL135235)
Received: 8 June 2023
Accepted: 4 August 2023
First Online: 17 August 2023
: The authors declare no competing interests.
: Both parent studies were approved by the University of North Carolina Institutional Review Board, and all participants provided informed consent/assent.
: Not applicable.